Charla A. DeBolt

Evaluation of the use of mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease.

M. Reeves, J. Boase, L. Jackson, 1996, The Pediatric infectious disease journal.

Vaccine Coverage at 36 Months and 7 Years by Parental Birth Country, Washington State.

Azadeh Tasslimi, J. Matheson, Charla A. DeBolt, 2024, Pediatrics.